We previously described the protective role of NFAT5 during hypoxia, in an independent way of HIF-1a. Alternatively, inducible NO synthase (iNOS) is also induced by hypoxia. The aim of this study was to establish the NFAT5 target gene in mouse embryonic fibroblasts (MEF) cell stimulated by hypoxia. NFAT5, iNOS, NO level, aquaporin 1 (AQP1) and urea transporter 1 (UTA1) were induced by low oxygen levels in MEF cells. Additionally, NFAT5 and UTA1 were induced in reoxygenation (after 24hrs of hypoxia). NFAT5 transactivation domain (TAD) was induced during hypoxia and hypoxia/reoxygenation. Two MEF cells line independently produced for altered NFAT5 (Knockout and DBD-mutant) lost the iNOS and AQP1 induction by low oxygen. The iNOS induction was recovered in NFAT5-KO MEF cells, when recombinant NFAT5 protein expression was reconstituted, but not for NFAT5 DBD-mutant MEF cells, explained by its dominant negative effect. Finally, we found a negative feedback loop of iNOS effect over NFAT5 protein abundance. This work provides a relevant information about signaling pathway of NFAT5 during adaptive responses to oxygen depletion.
INTRODUCTION
Hypoxia is a condition in which insufficient levels of oxygen are supplied to one or more tissues in the body. Molecular oxygen serves as the final electron acceptor in oxidative phosphorylation, and hence low oxygen supply increases the risk for generating reactive oxygen species (ROS), resulting in cell dysfunction and ultimately cell death. In this context, the nuclear factor of activated T cells 5 (NFAT5), a master regulator of the osmoprotective program, plays a protective role against hypoxia (independently of HIF-1a), but the signaling pathway is still under revision.
NFAT5 belongs to the Rel family of transcriptional activators, which includes NFκB.
Cells switching to hypertonic media, NFAT5 is translocated to the nuclei [1, 2] , where it binds to osmotic response elements (OREs) on target genes, increases activity of the transactivation domain (TAD) [3] . Activation of NFAT5 induces the intracellular accumulation of organic osmolytes and water transport, via induction of osmoregulatory target genes AR, UTA1, and membrane transporters AQPs, respectively [4] . In addition, NFAT5 mRNA and protein levels itself are increased by high NaCl, which confers an additional level of regulation by hypertonicity [1, 5, 6] . Besides hypertonic stimulation, NFAT5 also participates in isotonic gene expression regulation downstream of TLR4 and cytokine receptors, controlling expression of inflammatory target genes like IL-1β, IL-6, TNF-α and inducible nitric oxide synthase (iNOS) [7] [8] [9] [10] .
We have shown that NFAT5 is induced by hypoxic stimulation (0.1-2.5% O 2 ), increasing its nuclear translocation and transcriptional activity. Hypoxia and hypertonicity effects on NFAT5 induction are additive, and activation of NFAT5 during hypoxia is independent of the HIF1ɑ pathway [11] . Importantly, silencing of NFAT5 during hypoxia increased cleaved caspase-3 levels, suggesting a protective role of NFAT5 during hypoxic stimulation [11] .
Endogenous nitric oxide (NO) is synthesized by three isoforms of nitric oxide synthesizing enzymes (NOS). The isoform 2 (Nos2), also called inducible NOS (iNOS), is induced by hypoxia. iNOS use L-arginine (Arg) to metabolize it to Lcitrulline and NO. The iNOS enzyme is calcium-independent and its expression is 4 induced by several cytokines and immune regulators, ultimately by binding of transcription factors such as NFκB to its proximal promoter [12] .
Several studies have shown that hypoxia induces the expression of iNOS, which leads to the rapid production of NO. In turn, NO combines with superoxide anion to generate peroxynitrite, a highly toxic reactive nitrogen species (RNS) that causes lipid peroxidation, nitration of protein at tyrosine residues, activation of caspase-3, apoptosis and cell death [13, 14] . Whether NFAT5 is involved in this event is currently unknown. On the other hand, induction of iNOS by lipopolysaccharide (LPS) and TLR signaling causes impairment of renal NFAT5 function due to an increase in NFAT5 S-nitrosylation, which causes a reduction of NFAT5-target gene expression in the renal medulla (ClC-K1, UTA1 and AQP2) and a consecutive sepsis-induced urinary concentration defect [15] , indicating that iNOS can regulate NFAT5 activity during sepsis. Although this evidence points toward a functional reciprocity between these two signaling pathways, interaction of NFAT5 and iNOS signaling in the setting of hypoxia remains completely unexplored. Now we investigated the relationship between NFAT5 and iNOS in MEF wild type, knockout and mutant NFAT5 during hypoxia conditions. We found that protein expression and activity of NFAT5 was induced by hypoxia in MEF cells, leading to an increase in the expression of iNOS, AQP1 and UTA1, but not of AR or BGT1. supplemented with 2 mM L-Glutamine (HyClone), 1x Penicillin-Streptomycin (Gibco) and 10% Fetal Bovine Serum (Sigma). Pharmacological studies were done using aminoguanidine (AG, Tocris; 1mM) or L-Arg (500μM). Nitric oxide (NO) detection was performed in phenol red-free Opti-MEM1 using 5 μM of DAF-FM (Thermo). As a positive control for iNOS expression, incubation for 24 hours with 500 ng/mL LPS and 25 ng/mL IFNg was used.
Hypoxia and reoxygenation in cell culture. The hypoxia condition was obtained using a Heracell 150i CO 2 incubator (Thermos) coupled to a Drager-X-am MultiGas Detector system set at 1% O 2 ; 5% CO 2 ; and 37ºC [11] . A time course ranging from 4 to 48 hours was performed. The reoxygenation study was conducted after Luciferase assay. The binary GAL4 reporter system has been previously described [3] . To assess the activity of the NFAT5-TAD, cells were co-transfected with the GAL4 reporter (pFR-Luc) and GAL4dbd-548-1531, which contains the recombinant TAD. 24 h after transfection, cells were switched to hypoxia and luciferase activity was measured 16 h later using the Luciferase Assay System kit (Promega) and a Synergy 2 multi-detector microplate reader (Biotek).
Cell lysate preparation and Western blot analysis of mutant and wt MEF cells.
Adherent cells were lysed with cold PBS (1% TX-100), supplemented with protease inhibitor cocktail (Roche) and 1 mM PMSF (Sigma). Lysates were centrifuged at 10.000xg, 10 min at 4°C. Cleared lysates were determined using NFAT5 mRNA levels decreased rapidly after switching to 21% O 2 ( Figure 2A ).
However, levels of NFTA5 protein was transient induced during reoxygenation when compared to hypoxia. NFAT5 increased significantly from 8 h reoxygenation, peaking at 16 h, and then returning to the levels observed during hypoxia condition at 24-48 h ( Figure 2B ). The iNOS mRNA levels experimented a gradual decrease reaching a baseline level 48 hours after reoxygenation ( Figure 2C ). On the other hand, the iNOS protein expression levels fall rapidly during reoxygenation, but interestingly remained significantly above the baseline level (1.8 times) ( Figure   2D ). [11] . Now our results established that our transfection protocol had a 50% of transfection efficiency (GFP expression). The results showed that empty vector (pFRLuc co-transfected with pFA) did not produce a detectable luciferase activity. However, when cells were transfected with NFAT5-TAD a basal activity was observed in normoxia condition (20 URL, Figure   3 ). However, MEF cells exposed to hypoxia (24h), experimented higher transactivation activity than normoxia (52 URLs). Hypoxia/reoxygenation (24/16h) increased transactivation activity relative to basal condition (similar levels to observed in hypoxia). The positive control of transactivation activity reached an average of 170 URLs (16h hypertonicity) ( Figure 3 ). reoxygenation were high and equivalent to those detected during hypoxia, but then they fall gradually toward 48 hours ( Figure 5E ). UTA1 mRNA levels decreased quickly, returning to normoxia levels as soon as 8 hours after reoxygenation ( Figure 5F ). These results showed that in MEF cells hypoxia produced upregulation of iNOS, AQP1 and UTA1, after NFAT5 activation, but not during reoxygenation process, except for UTA-1.
NFAT5 target genes regulation under hypoxia conditions in MEF-NFAT5
-/-cells and pharmacological NO manipulation.
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To understand the role of NFAT5 on iNOS, AQP-1 and UTA1 induction by hypoxia, we use NFAT5 knockout cells (MEF-NFAT5 -/-). We confirm that NFAT5-KO cells do not express NFAT5 protein ( Figure 6A ). The induction of iNOS and AQP-1 by hypoxia was significant eliminated in MEF-NFAT5 -/-cells. These results suggest the participation of NFAT5 on iNOS and AQP-1 response to hypoxia in MEF cell ( Figure 6B ).
We tested the iNOS activity during hypoxia, measuring Nitric Oxide (NO) levels using a NO-sensitive probe. Also, we measurement the protein nitrotyrosilation levels (a product of NO levels) using a 3-NT antibody. The production of NO and 3 Figure 6B ), but not L-Arg ( Figure 6B ). These data suggest a interplay between Inducible Nitric Oxide Synthase and NFAT5 in hypoxic condition, as it has been described for osmotic regulation [18] .
As it was mentioned above, the AQP1 abundance in MEF-NFAT5 -/-cells were undetectable in all conditions tested ( Figure 6F ), indicating that basal and hypoxiainduced AQP1 expression was NFAT5-dependent. In wild type cells, the iNOS inhibitor (AG), increased significantly the AQP1 abundance in hypoxia (72% of AQP1), showed that AG treatment concomitantly improved the NFAT5 and AQP1
expression.
Regarding UTA1 regulation, we observed that UTA1 induction by hypoxia in wild type cells was partially lost with AG ( Figure 6G ). On the other hand, the L-Arg treatment induced UTA1 abundance in normoxia, but did not modified their levels in hypoxia condition ( Figure 6G ). Interestingly, MEF-NFAT5 -/-cells lost the induction of UTA1 by hypoxia compared to wild type cells, regardless of pharmacological NO manipulation ( Figure 6G ).
Full length human NFAT5 rescues hypoxia-induced effects on NFAT5 target genes in MEF-NFAT5 -/-cells, but not in MEF-NFAT5 D/D cells
The above results clearly suggest that the hypoxia-induced increase of AQP1 and iNOS levels were dependent on NFAT5 activity in MEF cells. To further confirm
this, we used MEF cells expressing a mutated version of NFAT5 (MEF-NFAT5 D/D ).
This NFAT5 mutant lacks residues 254-340 of NFAT5 and loses its ability to DNA binding [17] and enhanceosome formation [10] . In contrast to wild-type cells, the regulation [10] . We also observed rescue AQP1, but in less degree than iNOS ( Figure 9A ).
MEF-NFAT5

DISCUSION
Besides a master regulator for osmoadaptative responses to hypertonic stress [4] , mounting evidence supports now a leading role of NFAT5 as an essential factor for organ development [16, 19] , as an integral component of the immune response [7, 17] , a systemic surveillance factor for blood pressure control [20, 21] , a key regulator of the urine concentration mechanism for renal function [22] , and as a novel HIF1α-independent protective factor against hypoxia [11] . Therefore, NFAT5
can be considered as a pivotal transcription factor and integrator of multiple adverse stimulus for stress adaptation. Another molecule highly studied during hypoxia is NO, which mediates positive or adverse effects [23, 24] . Of the three isoforms that produce NO, iNOS enzyme is independent of intracellular calcium concentration and it has been described that it exerts a negative regulatory role for NFAT5-mediated signaling in the renal medulla during sepsis [15] . There are no studies to clarify NFAT5 and iNOS relationship in the setting of hypoxia and hypoxia/reoxygenation.
In MEF cells we found that NFAT5 and iNOS were induced shortly after hypoxia, starting 4 hours after stimulation. In the hypoxia/reoxigenation condition we found that NFAT5 presented a further increase although NFAT5 mRNA levels had returned to basal levels, suggesting protein stabilization mechanisms. However, the transactivation activity of NFAT5 was also increased in hypoxia and hypoxia/reoxygenation, confirming our previous results in HEK293 and rat primary IMCD cells [11] . Unexpectedly, reoxygenation reduced the expression of iNOS compared to hypoxia levels, but still remained higher than basal levels (1.8 times over normoxia condition). We found now that in hypoxia, AQP1 and UTA1 protein expression was increased in MEF cells. However, neither AR nor BGT1 levels changed upon stimulation, suggesting that hypertonic target genes are differentially regulated by NFAT5 during hypoxia, either via a signaling pathway independent of ORE, or being negatively affected by chromatin context during hypoxia.
Regardless mechanism, our results are in agreement with previous results showing that AR is not induced by hypoxia [25] . or iNOS even when recombinant NFAT5 was reconstituted, confirming previous report describing NFAT5 mutant as a dominant negative. Interestingly, this important result suggests that during hypoxia, iNOS and AQP1 gene expression are similarly regulated. Whether AQP1 is also stimulated via enhanceosome formation during hypoxia as for the Nos2 gene during isotonic immune regulation [10] , is currently unknown.
Our results showed that iNOS activity has a negative role on NFAT5 expression in response to hypoxia, which might be explained by a post-translational modification that increased its degradation, as it was previously described by NO-dependent modification upon LPS treatment [18] . During hypoxia, the inhibition of iNOS activity (AG), significantly increased the expression of NFAT5 and AQP1. The AG has been described as a selective inducible nitric oxide synthase inhibitor [26] .
However, other multiple biological effects have been postulated, including prevention of advanced glycation end products (AGEP) formation [27] , and inhibition of diamino oxidase [28] . We are currently exploring whether the effect of AG on NFTA5 and AQP1 could be related to the other biological activities of AG during hypoxia.
The expression of UTA1 at 24 hours after induction of hypoxia could be explained because hypoxia also induces arginase 2, which produces ornithine plus urea.
Arginase-2 is induced in hypoxia and constitutes a protective mechanism for the 14 deleterious effects of iNOS activity [29] . We propose that UTA1 upregulation was a secondary response to urea overproduction by hypoxia [30] . In MEF-NFAT5 -/-cells UTA1 is expressed in basal form, but hypoxia-UTA1 induction by was lost,
suggesting that NFAT5 participates in the induction of UTA1 during hypoxia as well. We are exploring this hypothesis.
In conclusion, these results confirm that NFAT5 is activated by hypoxia and hypoxia/reoxygenation. During hypoxia NFAT5 control the expression of AQP1 and iNOS. During hypoxia/reoxygenation, NFAT5 might control UTA1 gene expression.
Additionally, increased production of NO by iNOS inhibited the expression of NFAT5 during hypoxia. Therefore, there is a bidirectional communication between NFAT5 and iNOS signaling during cell adaptation to decreased oxygen supply.
These results improve the understanding for future pharmacological interventions during ischemic pathology.
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